Yingkun Xu

25PUBLICATIONS
20CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersBioinformatic methods developmentCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 26, 2026
Single-Cell and Machine Learning Analyses Identify MYDGF as an Immune-Related Biomarker Associated With the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.

|Aug 29, 2023
WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma

Jiechuan Qiu, Zicheng Wang, Peizhi Zhang

|Sep 19, 2022
Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients.

Yingkun Xu, Han Li, Ailin Lan

|Sep 09, 2022
Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.

Yingkun Xu, Meiying Shen, Yang Peng

|Sep 05, 2022
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer.

Yingkun Xu, Yudi Jin, Shun Gao

|Aug 19, 2022
Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma.

Xiunan Li, Jiayi Li, Leizuo Zhao

Pageof 5

Frequent Collaborators

14 joint publications

Guangzhen Wu

7 joint publications

Qifei Wang

5 joint publications

Xiangyu Che

5 joint publications

Shengchun Liu